The purpose of the Skin Substitute Access and Payment Reform Act of 2025 is to improve how Medicare pays for skin substitute products, which are advanced therapies used to treat chronic wounds like diabetic foot ulcers. The goal is to ensure that these products are more accessible and affordable for Medicare beneficiaries, while also recognizing their clinical value. Key provisions of the Act include a new payment structure for skin substitute products starting January 1, 2026. This structure will establish a volume-weighted average payment limit based on the costs of various products.